Stimulation of collagen biosynthesis by flavonoid glycosides in skin fibroblasts of osteogenesis imperfecta type I and the potential mechanism of their action

International Journal of Molecular Medicine

Volumn 20, Issue 6, 2007, Pages 889-895

  Galicka, Anna ^a   Jolanta, Nazaruk ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Collagen biosynthesis; Flavonoids; Osteogenesis imperfecta; Prolidase

Indexed keywords

COLLAGEN; FLAVONOID; GLYCOSIDE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; FIBROBLAST; HUMAN; METABOLISM; OSTEOGENESIS IMPERFECTA; SKIN;

ANIMALS; CELLS, CULTURED; COLLAGEN; FIBROBLASTS; FLAVONOIDS; GLYCOSIDES; HUMANS; MOLECULAR STRUCTURE; OSTEOGENESIS IMPERFECTA; SKIN;

EID: 42149125020     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.6.889     Document Type: Article

References (29)

1. Sillence DO, Senn A and Danks DM: Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 16: 101-116, 1979.
2. Prockop DJ: Mutations in collagen genes as a cause of connective-tissue diseases. N Engl J Med 326: 540-546, 1992.
3. Rauch F and Glorieux FH: Osteogenesis imperfecta. Lancet 363: 1377-1385, 2004.
4. Millington-Ward S, McMahon HP and Farrar GJ: Emerging therapeutic approaches for osteogenesis imperfecta. Trends Mol Med 11: 299-305, 2005.
5. Willing MC, Pruchno CJ, Atkinson M and Byers PH: Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet 51: 508-515, 1992.
6. Galicka A, Surazynski A, Wolczynski S, Palka J, Popko J and Gindzienski A: Phenotype variability in a daughter and father with mild osteogenesis imperfecta correlated with collagen and prolidase levels in cultured skin fibroblasts. Ann Clin Biochem 42: 80-84, 2005.
7. Harborne JB and Baxter H (eds): The Handbook of Natural Flavonoids. Wiley & Sons, Chichester, 1999.
8. Havsteen BH: The biochemistry and medical significance of the flavonoids. Pharmacol Ther 96: 67-202, 2002.
9. Phan TT, Sun L, Bay BH, Chan SY and Lee ST: Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring. J Trauma 54: 1212-1224, 2003.
10. Phan TT, See P, Tran E, Nguyen TT, Chan SY, Lee ST and Huynh H: Suppression of insulin-like growth factor signaling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids. Br J Dermatol 148: 544-552, 2003.
11. Kapoor M, Howard R, Hall I and Appleton I: Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats. Am J Pathol 165: 299-307, 2004.
12. Nazaruk J and Gudej J: Flavonoid compounds from the flowers of Cirsium rivulare (Jacq.) All. Acta Pol Pharm 60: 87-89, 2003.
13. Nazaruk J and Jakoniuk P: Flavonoid composition and antimicrobial activity of Cirsium rivulare (Jacq.) All. flowers. J Ethnopharmacol 102: 208-212, 2005.
14. Nazaruk J: Flavonoid aglycones and phytosterols from the Erigeron acris L. herb. Acta Pol Pharm 63: 317-319, 2006.
15. Peterkofsky B, Chojkier M and Bateman J: Determination of collagen synthesis in tissue and cell culture system. In: Immunochemistry of the Extracellular Matrix. Furthmay M (ed). CRC Press, Boca Raton, FL, pp19-47, 1982.
16. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
17. Carmichael J, Degraff W, Gazdar A, Minna J and Mitchell J: Evaluation of a tetrazolinium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987. (Pubitemid 17027905)
18. Unemori EN and Werb Z: Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 103: 1021-1031, 1986.
19. Myara I, Charpentier C and Lemonnier A: Optimal conditions for prolidase assay by proline colorimetric determination: application to imidodipeptiduria. Clin Chim Acta 125: 193-205, 1982.
20. Chinard FP: Photometric estimation of proline and ornithine. J Biol Chem 199: 91-95, 1952.
21. Labarca C and Paigen K: A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
22. Sartor L, Pezzato E, Dell'Aica I, Caniato R, Biggin S and Garbisa S: Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design. Biochem Pharmacol 64: 229-237, 2002.
23. Phang JM and Scriver CR: Disorders of proline and hydroxyproline metabolism. In: The Metabolic Basis of Inherited Disease. Scriver CR, Beaudet AL, Sly WS and Valle D (eds). McGraw Hill, New York, pp577-597, 1989.
24. Palka JA and Phang J: Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 67: 166-175, 1997.
25. Miltyk W, Karna E, Wolczynski S and Palka J: Insulin-like growth factor-I-dependent regulation of prolidase activity in cultured human skin fibroblasts. Mol Cell Biochem 189: 177-184, 1998.
26. Williams RJ, Spencer JP and Rice-Evans C: Flavonoids: Antioxidants or signaling molecules? Free Radic Biol Med 36: 838-849, 2004.
27. Galicka A, Wolczynski S, Anchim T, Surazynski A, Lesniewicz R and Palka J: Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta. Eur J Biochem 268: 2172-2178, 2001.
28. Galicka A, Wolczynski S, Gindzienski A, Surazynski A and Palka J: Gly511 to Ser substitution in the COL1A1 gene in osteogenesis imperfecta type III patients with increased turnover of collagen. Mol Cel Biochem 248: 49-56, 2003.
29. Labat-Robert J and Robert L: Interaction between cells and extracellular matrix: signaling by integrins and the elastin-laminin receptor. Prog Mol Subcell Biol 25: 57-70, 2000.